Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-05-22 @ 11:58 AM
Study NCT ID:
NCT03467958
Status:
TERMINATED
Last Update Posted:
2025-09-17
First Post:
2018-03-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Sponsor:
Celgene
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Crohn Disease | View |